Recombinant Human Interferon α2b for Injection

北京凯因科技股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 7LeaeWDc6GP
Approval Number: 国药准字S20090032
Generic Name: 注射用重组人干扰素α2b
Generic Name En: Recombinant Human Interferon α2b for Injection
Trade Name: 凯孚
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 300万国际单位/支,用1ml灭菌注射用水复溶。
Reg Date: 2021-09-06
Company Name: 北京凯因科技股份有限公司
Company Address: 北京市北京经济技术开发区荣京东街6号3号楼
Production Company Name: 北京凯因科技股份有限公司
Production Company Address: 北京市北京经济技术开发区荣京东街6号
Company Detail Path: /organization/beijing-kawin-technology-share-holding-co-ltd
Production Company Detail Path: /organization/beijing-kawin-technology-share-holding-co-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 6, 2021

Approval ID

7LeaeWDc6GP

Type

生物制品